DOI 10.1186/s12876-026-04933-z
Prognostic model for patients with hepatoid adenocarcinoma of the stomach.
Аннотация
INTRODUCTION
Hepatoid adenocarcinoma of the stomach (HAS) is a rare form of gastric cancer. This study assessed the impact of tumor node metastasis (TNM) stage on survival in HAS compared with non-HAS patients, identified prognostic factors, and developed a predictive nomogram.
METHODS
Patients diagnosed with HAS between September 2012 and August 2022 were retrospectively analyzed. Clinical characteristics and survival outcomes were compared between HAS and non-HAS groups before and after TNM stage matching. Prognostic factors were determined using Kaplan-Meier and Cox regression analyses, and nomograms were constructed for survival prediction.
RESULTS
Without stage matching, HAS patients showed significantly worse survival than non-HAS patients (HR = 3.09, 95% CI: 2.05-4.67, p < 0.001). After TNM stage matching, no significant difference was observed (HR = 1.14, 95% CI: 0.79-1.64, p = 0.476). The nomogram model incorporating Sal-like protein 4 (SALL4), serum iron (Fe), and free prostate-specific antigen (fPSA) accurately predicted overall survival (AUC = 0.946, 95% CI: 0.897-0.994).
CONCLUSIONS
These findings suggest that poorer outcomes in HAS are primarily due to advanced TNM stages, and that SALL4, serum Fe, and fPSA serve as key prognostic indicators.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.